How COVID-19 Compromised U.S. Gains in Controlling HIV
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
University of California San Francisco
Give to UCSF
Lancet Commission Calls for Renewed Global Response on TB
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
Can We Stamp Out HIV? New Monthly Injections Could Offer Hope
Taking daily medication can be a challenge for many, leading to increased viral load over time. Injectable therapies remove that challenge.
Don’t Take Chances: Why Doxycycline is a Great Bet Against STIs
A short course of antibiotics, Doxy-PEP, can prevent some STIs after condomless sex.
Doxycycline for STI Prevention: Highly Effective, Minimal Drug Resistance
A sexual health strategy called Doxy-PEP, which involves taking doxycycline after condomless sex, is highly effective in reducing bacterial STIs but is still associated with a limited rise in resistant strains of bacteria.
Researchers Receive High Honors for Outstanding Science Contributions
Three UCSF researchers were named 2022 fellows by the American Association for the Advancement of Science (AAAS), one of the highest honors in science.
Ward 86 at 40: Shaping HIV Care Around the World
Since 1983, Ward 86 has played a revolutionary role in HIV/AIDS treatment, and continues to develop ways to care for people living with HIV.
Do Sexual Orientation and Gender Identity Affect Your Stroke Risk?
People who identify as lesbian, gay, bisexual, transgender or non-binary may have a higher risk for stroke at a younger age, and possibly a higher risk for recurrence than those who identify as straight and cisgender.
Doxycycline After Unprotected Sex Significantly Reduced STIs
A significant proportion of bacterial sexually transmitted infections – gonorrhea, chlamydia, or syphilis – were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial.
Treating Anal Cancer Precursor Lesions Reduces Cancer Risk for People With HIV
A groundbreaking national study led by UCSF finds that treating anal cancer precursor lesions reduces cancer risk for people with HIV.
Faster Test Results Mean Better Outcomes For HIV Patients
Scientists at UCSF and Makerere University in Kampala, Uganda have developed an intervention that makes use of a portable laboratory testing technology to help HIV providers order, process, and receive HIV viral load results quickly, and shorten the time it takes for patients to get their results.
Sudden Cardiac Death More Likely to Fell Persons with HIV Infection
Individuals with HIV are more than twice as likely to die from sudden cardiac death (SCD) compared to the general population, and more likely to have hearts compromised by fibrosis, a factor that may play a role in increasing their susceptibility to SCD, according to new findings from a UCSF study.
AIDS at 40: Sexism, Structural Racism and Discrimination Continues for HIV and COVID-19
This is one of the first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19.
